The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Cited by (1,044)

Items 301–400 of 1,044

1. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
   Heart Failure Society of America · 1999 · Journal of Cardiac Failure
2. Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory Adipokines
   Guo, Christine, Ricchiuti, Vincent, Lian, Bill Q., Yao, Tham M., Coutinho, Patricia, Romero, José R., Li, Jianmin, Williams, Gordon H., Adler, Gail K. · 2008 · Circulation
3. Aldosterone Production Is Activated in Failing Ventricle in Humans
   Yuji Mizuno, Michihiro Yoshimura, Hirofumi Yasue, Tomohiro Sakamoto, Hisao Ogawa, Kiyotaka Kugiyama, Eisaku Harada, Masafumi Nakayama, Shota Nakamura, Teruhiko Ito et al. · 2001 · Circulation
4. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
   Ziff, Oliver J, Lane, Deirdre A, Samra, Monica, Griffith, Michael, Kirchhof, Paulus, Lip, Gregory Y H, Steeds, Richard P, Townend, Jonathan, Kotecha, Dipak · 2015 · BMJ
5. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up
   Denis Duboc, Christophe Meune, Bertrand Pierre, Karim Wahbi, B. Eymard, Annick Toutain, Carole Berard, Guy Vaksmann, Simon Weber, Henri Marc Bécane · 2007 · American Heart Journal
6. Cardiorenal Syndrome Revisited
   Faiez M. Zannad, Patrick Rossignol · 2018 · Circulation
7. 2023 ESC Guidelines for the management of acute coronary syndromes
   Robert A. Byrne, Xavier Rosselló, John Joseph Coughlan, Emanuele Barbato, Colin Berry, Alaide Chieffo, Marc J. Claeys, Gheorghe‐Andrei Dan, Marc Richard Dweck, Mary Galbraith et al. · 2023 · European Heart Journal Acute Cardiovascular Care
8. Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)
   MICHAEL J. DOMANSKI, James E. Norman, Bertram Pitt, Mark C. Haigney, Stephen U. Hanlon, Eliot G. Peyster · 2003 · Journal of the American College of Cardiology
9. Aldosterone: effects on the kidney and cardiovascular system
   Marie B Briet, Ernesto L. Schiffrin · 2010 · Nature Reviews Nephrology
10. The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary
    Richard Kirk, Anne I. Dipchand, David N. Rosenthal, Linda J. Addonizio, Michael Burch, Maryanne Chrisant, Anne Marie Dubin, Melanie D. Everitt, Robert J. Gajarski, Luc Mertens et al. · 2014 · The Journal of Heart and Lung Transplantation
11. Cardiac fibrosis and arrhythmogenesis: The road to repair is paved with perils
    Thao Phuong Nguyen, Zhilin Qu, James N. Weiss · 2013 · Journal of Molecular and Cellular Cardiology
12. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure
    Frederick A. Masoudi, Edward P. Havranek, Pam Wolfe, Cary Philip Gross, Saif S. Rathore, John F. Steiner, Diana L. Ordin, Harlan M. Krumholz · 2003 · American Heart Journal
13. Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
    Gary Michael Felker, Vic Hasselblad, Adrian F. Hernandez, Christopher M. O’Connor · 2009 · American Heart Journal
14. The effects of exercise training on sympathetic neural activation in advanced heart failure
    Fabiana Roveda, Holly R. Middlekauff, Maria Urbana Pinto Brandão Rondon, Soraya F. Reis, Márcio Souza, Luciano Nastari, Antônio Carlos Pereira Barretto, Eduardo Moacyr Krieger, Carlos Eduardo Negrão · 2003 · Journal of the American College of Cardiology
15. Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology
    Frédéric Jaisser, Nicolette Farman · 2015 · Pharmacological Reviews
16. 2014 ESC/EACTS Guidelines on myocardial revascularization
    Stephan Windecker, Philippe H. Kolh, Fernándo Alfonso, Jean‐Philippe Collet, Jochen Cremer, Volkmar Falk, Gerasimos S Filippatos, Christian W. Hamm, Stuart J. Head, Peter Jüni et al. · 2015 · EuroIntervention
17. Immune Cell and Other Noncardiomyocyte Regulation of Cardiac Hypertrophy and Remodeling
    Ryan A. Frieler, Richard M. Mortensen · 2015 · Circulation
18. Characterization of Heart Failure Patients with Mid-Range Left Ventricular Ejection Fraction—a Report from the CHART-2 Study
    Kanako Tsuji, Yasuhiko Sakata, Kotaro Nochioka, Masanobu Miura, Takeshi Yamauchi, Takeo Onose, Ruri Abe, Takuya Oikawa, Shintaro Kasahara, Masayuki Sato et al. · 2017 · European Journal of Heart Failure
19. Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure
    Mihai Gheorghiade, Michael Böhm, Stephen John Greene, Gregg C. Fonarow, Eldrin Foster Lewis, Faiez M. Zannad, Scott David Solomon, Fabio Baschiera, Jaco Botha, Tsushung A. Hua et al. · 2013 · JAMA
20. Sex and Gender Differences in Myocarditis and Dilated Cardiomyopathy
    Fairweather, DeLisa, Cooper, Leslie T., Blauwet, Lori A. · 2013 · Current Problems in Cardiology
21. Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism
    Armanini, Decio, Boscaro, Marco, Bordin, Luciana, Sabbadin, Chiara · 2022 · International Journal of Molecular Sciences
22. B-Type Natriuretic Peptide–Guided Heart Failure Therapy
    Pramote Porapakkham · 2010 · Archives of Internal Medicine
23. The Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological Biology
    Say Viengchareun, Damien Le Menuet, Lætitia Martinerie, Mathilde Munier, Laurent Pascual-Le Tallec, Marc Lombès · 2007 · Nuclear Receptor Signaling
24. Antidepressant-Induced Sexual Dysfunction
    Gregorian, Razmic S, Golden, Katharine A, Bahce, Asena, Goodman, Clifford, Kwong, W Jacqueline, Khan, Zeba M · 2002 · Annals of Pharmacotherapy
25. Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction
    Masaru Hayashi, Takayoshi Tsutamoto, Atsuyuki Wada, Takashi Tsutsui, Chitose Ishii, Keijin Ohno, Masanori Fujii, Atsushi Taniguchi, Tomokazu Hamatani, Yoshitaka Nozato et al. · 2003 · Circulation
26. Gender differences in the effects of cardiovascular drugs
    Juan Luis Tamargo, Giuseppe M.C. Rosano, Thomas Walther, Juan Duarte, Alexander Niessner, JC Kaski, Claudio Ceconi, Heinz Drexel, Keld P. Kjeldsen, Gianluigi Savarese et al. · 2016 · European Heart Journal - Cardiovascular Pharmacotherapy
27. Aldosterone and end-organ damage
    Nancy Jeanne Brown · 2005 · Current Opinion in Nephrology & Hypertension
28. The effects of cognitive impairment on mortality among hospitalized patients with heart failure
    Giuseppe Zuccalà, Claudio Pedone, Matteo Cesari, Graziano Onder, Marco Pahor, Emanuele Marzetti, Maria Rita Lo Monaco, Alberto Cocchi, Pierugo Carbonin, Roberto Bernabei · 2003 · The American Journal of Medicine
29. Ventricular–Vascular Interaction in Heart Failure
    Barry A. Borlaug, David A. Kass · 2008 · Heart Failure Clinics
30. Chagas' Heart Disease
    Anis Rassi, Anis Rassi, William C. Little · 2000 · Clinical Cardiology
31. Aldosterone mediates angiotensin II‐induced interstitial cardiac fibrosis via a Nox2‐containing NADPH oxidase
    Sofian Johar, Alison C. Cave, Anilkumar Narayanapanicker, David Grieve, Ajay M. Shah · 2006 · The FASEB Journal
32. Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure
    Swedberg, Karl, Zannad, Faiez, McMurray, John J.V., Krum, Henry, van Veldhuisen, Dirk J., Shi, Harry, Vincent, John, Pitt, Bertram · 2012 · Journal of the American College of Cardiology
33. Reducing the Cost of Frequent Hospital Admissions for Congestive Heart Failure
    Anthony F. Jerant, Rahman S. Azari, Thomas S. Nesbitt · 2001 · Medical Care
34. The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment
    Anand Vaidya, Paolo Mulatero, Rene F. Baudrand, Gail Kurr Adler · 2018 · Endocrine Reviews
35. Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure
    Finlay Aleck McAlister, Justin Adrian Ezekowitz, Natasha Wiebe, Brian Hunter Rowe, Carol Spooner, Ellen T Crumley, Lisa Hartling, Terry Paul Klassen, William T. Abraham · 2004 · Annals of Internal Medicine
36. Possible Contributions of Reactive Oxygen Species and Mitogen-Activated Protein Kinase to Renal Injury in Aldosterone/Salt-Induced Hypertensive Rats
    Akira Nishiyama, Li Yao, Yukiko Nagai, Kayoko Miyata, Masanori Yoshizumi, Shoji Kagami, Shuji Kondo, Hideyasu Kiyomoto, Takatomi Shokoji, Shoji Kimura et al. · 2004 · Hypertension
37. Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association
    Brian Feingold, William T. Mahle, Scott R. Auerbach, Paula R. Clemens, Andrea A. Domenighetti, John L. Jefferies, Daniel Philip Judge, Ashwin K. Lal, Larry Wayne Markham, W. James Parks et al. · 2017 · Circulation
38. 2020 Clinical practice guidelines for Stable coronary artery disease
    Russian Society of Cardiology · 2020 · Russian Journal of Cardiology
39. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
    Sharon A. Hunt, William T. Abraham, Marshall H. Chin, Arthur Michael Feldman, Gary S. Francis, Théodore G. Ganiats, Mariell L Jessup, Marvin A. Konstam, DONNA M. MANCINI, Keith Michl et al. · 2005 · Journal of the American College of Cardiology
40. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
    Massimo Volpe, M Carnovali, Vittoria Mastromarino · 2015 · Clinical Science
41. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association
    Arnold, Suzanne V., Bhatt, Deepak L., Barsness, Gregory W., Beatty, Alexis L., Deedwania, Prakash C., Inzucchi, Silvio E., Kosiborod, Mikhail, Leiter, Lawrence A., Lipska, Kasia J., Newman, Jonathan D. et al. · 2020 · Circulation
42. 5-Hydroxytryptamine receptors in the human cardiovascular system
    Alberto Julio Kaumann, Finn Olav Levy · 2006 · Pharmacology & Therapeutics
43. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
    H.‐H. Parving, Barry Morton Brenner, John J.V. McMurray, Dick de Zeeuw, Steven M. Haffner, Scott David Solomon, Nish Chaturvedi, Mathieu M. Ghadanfar, Nicole Weissbach, Z. Xiang et al. · 2009 · Nephrology Dialysis Transplantation
44. Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure
    Amanda J. Rickard, James Morgan, Greg H. Tesch, John W. Funder, Peter J. Fuller, Morag J. Young · 2009 · Hypertension
45. Mitochondria-Rich Extracellular Vesicles From Autologous Stem Cell–Derived Cardiomyocytes Restore Energetics of Ischemic Myocardium
    Gentaro Ikeda, Michelle Rai Santoso, Yuko Tada, Albert Mao Li, Evgeniya A. Vaskova, Ji‐Hye Jung, Connor O’Brien, Elizabeth S. Egan, Jiangbin Ye, Phillip Chung-Ming Yang · 2021 · Journal of the American College of Cardiology
46. Patient Complexity: More Than Comorbidity. The Vector Model of Complexity
    Monika M. Safford, Jeroan J. Allison, Catarina I. Kiefe · 2007 · Journal of General Internal Medicine
47. SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
    Muhammad A Abdul‐Ghani, Stefano Del Prato, ROBERT J. CHILTON, Ralph Anthony DeFronzo · 2016 · Diabetes Care
48. Effects of Aldosterone on the Vasculature
    Ernesto L. Schiffrin · 2006 · Hypertension
49. Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy
    Kasper Rossing, Katrine Jordan Schjoedt, U. Smidt, Frans Boomsma, Hans‐Henrik Parving · 2005 · Diabetes Care
50. Heart and Lung Transplantation Developed in Collaboration With the International Society for Guidelines Cardiology Foundation/American Heart Association Task Force on Practice Management of Heart Failure in Adults: A Report of the American College of 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and
    Théodore G. Ganiats, Marvin A. Konstam, DONNA M. MANCINI, William T. Abraham, Donald E. Casey, Arthur Michael Feldman, Gary S. Ma · 2009
51. Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure
    Gülmisal Güder, Johann K Bauersachs, Stefan Frantz, Dirk Weismann, Bruno Allolio, Georg Ertl, Christiane E. Angermann, Stefan Störk · 2007 · Circulation
52. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function
    Taves, Matthew D., Gomez-Sanchez, Celso E., Soma, Kiran K. · 2011 · American Journal of Physiology-Endocrinology and Metabolism
53. Update on tissue renin–angiotensin systems
    Michael Bäder, Detlev Ganten · 2008 · Journal of Molecular Medicine
54. Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone’s Antifibrotic Activity
    Grune, Jana, Beyhoff, Niklas, Smeir, Elia, Chudek, Remigiusz, Blumrich, Annelie, Ban, Zsofia, Brix, Sarah, Betz, Iris R., Schupp, Michael, Foryst-Ludwig, Anna et al. · 2018 · Hypertension
55. The syndrome of cardiac cachexia
    Stefan D. Anker, Rakesh Sharma · 2002 · International Journal of Cardiology
56. Gender and the renin–angiotensin–aldosterone system
    Kimiaki Komukai, Seibu Mochizuki, Michihiro Yoshimura · 2010 · Fundamental and Clinical Pharmacology
57. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
    Clyde W. Yancy, Mariell L Jessup, Biykem Bozkurt, Javed Butler, Donald E. Casey, Mark H. Drazner, Gregg C. Fonarow, Stephen A. Geraci, Tamara B. Horwich, James L. Januzzi et al. · 2013 · Journal of the American College of Cardiology
58. A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study
    Christian Holubarsch, Martin Rohrbach, Matthias Karrasch, Erich Boehm, Lech Poloński, Piotr P. Ponikowski, Siegfried Rhein · 2007 · Clinical Science
59. Torcetrapib‐induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone
    M J Forrest, Daniel M. Bloomfield, Richard J. Briscoe, Patricia N. Brown, A‐M Cumiskey, J Ehrhart, James C. Hershey, W J Keller, Xiaochun Ma, Holly E. McPherson et al. · 2008 · British Journal of Pharmacology
60. Outcomes After Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Markedly Reduced Left Ventricular Function
    Hari P. Chaliki, Dania Mohty, Jean-François Aviérinos, Christopher G. Scott, Hartzell Vernon Schaff, Abdul Jamil Tajik, Maurice L. Enriquez-Sarano · 2002 · Circulation
61. Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
    Natalia Muñoz‐Durango, Cristóbal Fuentes, Andrés Castillo, Luis M González-Gómez, Andrea Vecchiola, Carlos Fardella, Alexis M. Kalergis · 2016 · International Journal of Molecular Sciences
62. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
    McDonald, Michael, Virani, Sean, Chan, Michael, Ducharme, Anique, Ezekowitz, Justin A., Giannetti, Nadia, Heckman, George A., Howlett, Jonathan G., Koshman, Sheri L., Lepage, Serge et al. · 2021 · Canadian Journal of Cardiology
63. Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease
    Nicola C. Edwards, Richard Paul Steeds, Paul M. Stewart, Charles Joseph Ferro, John Townend · 2009 · Journal of the American College of Cardiology
64. Functional Mineralocorticoid Receptors in Human Vascular Endothelial Cells Regulate Intercellular Adhesion Molecule-1 Expression and Promote Leukocyte Adhesion
    Massimiliano Caprio, Brenna G. Newfell, Andrea Sala, Wendy E. Baur, Andrea Fabbri, Giuseppe M.C. Rosano, Michael E. Mendelsohn, Iris Zamir Jaffe · 2008 · Circulation Research
65. Hallmarks of cardiovascular ageing
    Mahmoud Abdellatif, Peter P. Rainer, Simon Sedej, Guido Kroemer · 2023 · Nature Reviews Cardiology
66. Serum Soluble ST2
    Robin A.P. Weir, Ashley M. Miller, Grace Murphy, Suzanne E. Clements, Tracey Steedman, John Connell, Iain B. McInnes, Henry J. Dargie, John J.V. McMurray · 2010 · Journal of the American College of Cardiology
67. A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
    Parthasarathy, Hari K, Ménard, Joel, White, William B, Young, William F, Williams, Gordon H, Williams, Bryan, Ruilope, Luis Miguel, McInnes, Gordon T, Connell, John M, MacDonald, Thomas M · 2011 · Journal of Hypertension
68. Telomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure
    Pim van der Harst, Gerrit van der Steege, Rudolf A. de Boer, Adriaan A. Voors, Alistair S. Hall, Marcel J. Mulder, Wiek H. van Gilst, Dirk Jan van Veldhuisen · 2007 · Journal of the American College of Cardiology
69. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction—Executive Summary
    Jeffrey L. Anderson, Cynthia D. Adams, Elliott Marshall Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin et al. · 2007 · Journal of the American College of Cardiology
70. Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy
    Goodfriend, Theodore L., Calhoun, David A. · 2004 · Hypertension
71. Observational Study Mortality in Treated Primary Aldosteronism
    Martín Reincke, Evelyn Fischer, Sabine Gerum, Katrin Merkle, Sebastian Schulz, Anna Pallauf, Marcus O. Quinkler, Gregor Hanslik, Katharina Lang, Stefanie Hahner et al. · 2012 · Hypertension
72. The prognostic importance of anemia in patients with heart failure
    Mikhail Kosiborod, Grace L. Smith, Martha J. Radford, JoAnne M. Foody, Harlan M. Krumholz · 2003 · The American Journal of Medicine
73. Cardiac Resynchronization Therapy in Advanced Heart Failure the Multicenter InSync Clinical Study
    Daniel Gras, Christophe Leclercq, ANTHONY S.L. TANG, C. A. Bucknall, Henk Oude Luttikhuis, Anders Kirstein Pedersen · 2002 · European Journal of Heart Failure
74. High rate of detection of primary aldosteronism, including surgically treatable forms, after ???non-selective??? screening of hypertensive patients
    Michael Stowasser, Richard D. Gordon, Thanuja G Gunasekera, Diane Cowley, Gregory Ward, Colin Archibald, Bernard Mark Smithers · 2003 · Journal of Hypertension
75. Torasemide in Chronic Heart Failure: Results of the TORIC Study
    Juan Cosín, Javier Dı́ez · 2002 · European Journal of Heart Failure
76. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review
    Lars G. Olsson, Karl B Swedberg, Andrew L. Clark, Klaus Karl Witte, John G.F. Cleland · 2005 · European Heart Journal
77. New approaches in the treatment of hypertension
    Oparil, Suzanne, Schmieder, Roland E. · 2015 · Circulation Research
78. Diuretic response in acute heart failure—pathophysiology, evaluation, and therapy
    Jozine M. ter Maaten, Mattia A. E. Valente, Kevin Damman, Hans L. Hillege, Gerjan J Navis, Adriaan A. Voors · 2015 · Nature Reviews Cardiology
79. Central regulation of sodium appetite
    Joel C. Geerling, Arthur D. Loewy · 2007 · Experimental Physiology
80. Influence of Baseline and Worsening Renal Function on Efficacy of Spironolactone in Patients With Severe Heart Failure
    Orly Vardeny, Dong Hong Wu, Akshay Suvas Desai, Patrick Rossignol, Faiez M. Zannad, Bertram Pitt, Scott David Solomon · 2012 · Journal of the American College of Cardiology
81. Patient Profiling in Heart Failure for Tailoring Medical Therapy. A Consensus Document of the Heart Failure Association of the European Society of Cardiology
    Giuseppe M.C. Rosano, Brenda Moura, Marco Metra, Michael Böhm, Johann K Bauersachs, Tuvia Ben Gal, Stamatis N. Adamopoulos, Magdy Abdelhamid, Vasiliki Bistola, Jelena Čelutkienė et al. · 2021 · European Journal of Heart Failure
82. Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence
    Rossing, Peter, Caramori, M. Luiza, Chan, Juliana C.N., Heerspink, Hiddo J.L., Hurst, Clint, Khunti, Kamlesh, Liew, Adrian, Michos, Erin D., Navaneethan, Sankar D., Olowu, Wasiu A. et al. · 2022 · Kidney International
83. Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
    Akshay Suvas Desai, Eldrin Foster Lewis, Rebecca Li, Scott David Solomon, Susan F. Assmann, Robin Boineau, Nadine Clausell, Rafael Díaz, Jerome L. Fleg, И. Г. Гордеев et al. · 2011 · American Heart Journal
84. Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline
    Heart Failure Society of America · 2010 · Journal of Cardiac Failure
85. Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines
    Paul Fraser Kantor, Jane Lougheed, Adrian Dancea, Michael Hugh McGillion, Nicole Barbosa, Carol Chan, Rejane F. Dillenburg, Joseph Atallah, Holger Buchholz, Catherine Chant-Gambacort et al. · 2013 · Canadian Journal of Cardiology
86. 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
    Jeffrey L. Anderson, Cynthia D. Adams, Elliott Marshall Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin et al. · 2013 · Circulation
87. Discovery of BAY 94‐8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases
    Lars Bärfacker, Alexander Kühl, Alexander Hillisch, Rolf Grosser, Santiago Figueroa‐Pérez, Heike Heckroth, Adam Nitsche, Jens‐Kerim Ergüden, Heike Gielen‐Haertwig, Karl‐Heinz Schlemmer et al. · 2012 · ChemMedChem
88. 2020 ACC/AHA guideline for the management of patients with valvular heart disease
    Otto, Catherine M., Nishimura, Rick A., Bonow, Robert O., Carabello, Blase A., Erwin, John P., Gentile, Federico, Jneid, Hani, Krieger, Eric V., Mack, Michael, McLeod, Christopher et al. · 2021 · The Journal of Thoracic and Cardiovascular Surgery
89. Treatment of Acne Vulgaris
    Aamir Haider · 2004 · JAMA
90. Conditional Mineralocorticoid Receptor Expression in the Heart Leads to Life-Threatening Arrhythmias
    Antoine Ouvrard‐Pascaud, Yannis Sainte–Marie, Jean‐Pierre Bénitah, Romain Perrier, Christelle Soukaseum, Aurélie Nguyen Dinh Cat, Anne Royer, Khaï Le Quang, Flavien Charpentier, Sophie Demolombe et al. · 2005 · Circulation
91. Diastolic Heart Failure
    Michael M. Givertz, James C. Fang · 2006 · CRC Press eBooks
92. A Comparison of the Aldosterone‐blocking Agents Eplerenone and Spironolactone
    Allan D. Struthers, Henry Krum, Gordon H. Williams · 2008 · Clinical Cardiology
93. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
    Nicoline Jochmann, Karl Stangl, Edeltraut Garbe, Gert Baumann, Verena Stangl · 2005 · European Heart Journal
94. Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I
    Michael Stowasser, James E. Sharman, Rodel Leano, Richard D. Gordon, Gregory Ward, Diane Cowley, Thomas Hugh Marwick · 2005 · The Journal of Clinical Endocrinology & Metabolism
95. Echocardiography in Heart Failure
    James N. Kirkpatrick, Mani A. Vannan, Jagat Narula, Roberto Miguel Lang · 2007 · Journal of the American College of Cardiology
96. Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy
    Hideo Izawa, Toyoaki Murohara, Kohzo Nagata, Satoshi Isobe, Hiroyuki Asano, Tetsuya Amano, Sahoko Ichihara, Tomoko Kato, Satoru Ohshima, Yosuke Murase et al. · 2005 · Circulation
97. Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease
    Sankar Dass Navaneethan, Sagar U. Nigwekar, Ashwini R. Sehgal, Giovanni FM Strippoli · 2009 · Clinical Journal of the American Society of Nephrology
98. Low-renin status in therapy-resistant hypertension: a clue to efficient treatment
    Eide, Ivar K, Torjesen, Peter A, Drolsum, Anders, Babovic, Almira, Lilledahl, Nils P · 2004 · Journal of Hypertension
99. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance
    Signe Skovgaard Wiese, Jens Dahlgaard Hove, Flemming Bendtsen, Søren Møller · 2013 · Nature Reviews Gastroenterology & Hepatology
100. Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors
     Matthew R. Weir, Mark Rolfe · 2010 · Clinical Journal of the American Society of Nephrology